Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search: ("physician" OR "physical")
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Retain my current filters
author_facet:"Canadian Agency for Drugs and Technologies in Health"
dewey-ones:"140 - Specific philosophical schools"
product_txtF_mv:"National Center for Biotechnology Information"
Search alternatives
:
"physician" »
"physicians"
Showing
1
-
6
of
6
Search:
'("physician" OR "physical")'
,
query time: 0.19s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
1
Reslizumab (Cinqair)
Published 2017
Canadian Agency for Drugs and Technologies in Health
“
... Severe asthma can have a profound effect on patients' day-to-day lives, such as limiting
physical
...
”
Read Now
2
Reslizumab (Cinqair)
Published 2017
Canadian Agency for Drugs and Technologies in Health
“
... Severe asthma can have a profound effect on patients' day-to-day lives, such as limiting
physical
...
”
Read Now
3
CADTH Canadian Drug Expert Committee recommendation: Tocilizumab (Actemra - Hoffmann-La Roche Limited) : indication : giant cell arteritis
Published 2018
CADTH
“
...
physician
with experience in the diagnosis and management of GCA. A reduction in price...
”
Read Now
4
CADTH Canadian Drug Expert Committee recommendation: Tocilizumab (Actemra - Hoffmann-La Roche Limited) : indication : giant cell arteritis
Published 2018
CADTH
“
...
physician
with experience in the diagnosis and management of GCA. A reduction in price...
”
Read Now
5
CADTH Canadian Drug Expert Committee recommendation: Brolucizumab (Beovu -- Novartis Pharmaceuticals Canada Inc.) : indication : treatment of neovascular (wet) age-related macular...
Published 2020
Canadian Agency for Drugs and Technologies in Health
“
... in patients with disease activity, based on the
physician
assessment...
”
Read Now
6
CADTH Canadian Drug Expert Committee recommendation: Brolucizumab (Beovu -- Novartis Pharmaceuticals Canada Inc.) : indication : treatment of neovascular (wet) age-related macular...
Published 2020
Canadian Agency for Drugs and Technologies in Health
“
... in patients with disease activity, based on the
physician
assessment...
”
Back
Narrow Search
Remove Filters
Clear Filter
Author: Canadian Agency for Drugs and Technologies in Health
Clear Filter
Classification: 140 - Specific philosophical schools
Clear Filter
Collection: National Center for Biotechnology Information
Year of Publication
From:
To:
Classification
140 - Specific philosophical schools
610 - Medicine & health
4
330 - Economics
2
700 - The arts; fine & decorative arts
2
Language
English
6
Collection
National Center for Biotechnology Information
Author
Canadian Agency for Drugs and Technologies in Health
CADTH Canadian Drug Expert Committee
4
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?filter%5B%5D=author_facet%3A%22Canadian+Agency+for+Drugs+and+Technologies+in+Health%22&filter%5B%5D=dewey-ones%3A%22140+-+Specific+philosophical+schools%22&filter%5B%5D=product_txtF_mv%3A%22National+Center+for+Biotechnology+Information%22&lookfor=%28%22physician%22+OR+%22physical%22%29&type=AllFields
Send by Email
×
Loading...